Business in the Burbs

EpiCept reports positive study of skin cream

January

EpiCept Corp. announced positive results from a study of a skin cream that is under development at the Eastview-based biotech company. The cream, designed to relieve nerve pain, performed better than a placebo cream and at least as well as a generic cream, according to EpiCept. Jack Talley, president and chief executive officer, said that the favorable results may help EpiCept find a partner to help develop the cream.

This entry was posted on Tuesday, January 27th, 2009 at 3:36 pm by Jay Loomis. You can follow any responses to this entry through the RSS 2.0 feed.
Category: Biopharmaceutical

Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.